The new study led by the researchers from a center for the disease control and also prevention finds which rates of the high grade of cervical lesions among the young women in the United States fell dramatically in between 2008 & 2012, the few years after the HPV vaccination introduced in the United States.
While the findings show that the HPV vaccination contributed into the reduction, a researcher say that may be down to the changes in the cervical screening recommendations which occurred in the year of 2012. Over 50 percent of the high grade of the cervical lesions caused by the persistent HPV infection and most HPV types 16 & 18. They will be prevented with the HPV vaccination.
An HPV vaccine Gardasil that protects against the HPV types 6 & 11 is known to cause the genital warts has approved by the United States food and the drug administration in the year of 2006. In the year of 2009, the other HPV vaccine, Cervarix is approved to protect against the HPv types 16 & 18.
This is according to a center for the disease control and the prevention, the girls aged 11 & 12 have recommended to receive the HPV vaccination in the three doses, are girls and the women aged 13 to 26 who are not already vaccinated.
High Grade Cervical Lesions In Women Aged 18 To 20:
For the study, published in a journal cancer, is the lead author Susan Hariri, of a division of the STD prevention at a CDC and also her team is set out to estimate a rate of the high grade of the cervical lesion among the American women aged 18 to 39 in between the year of 20018 & 2012. All of the women included in a study from the catchment areas in the California, Oregon or Connecticut, New York and is part of an HPV IMPACT project that monitors a population impact of the HPV vaccination.
The incidence of the high grade of cervical lesions among a woman is identified via the manual chart review and the electronic health records and a team applied a Cochran Armitage test to assess the trends in the incidence of the locations. The researchers used the administrative and the survey data to estimate a rate of the annual cervical screening in the California, Oregon and New York. All of the researchers gave the best thing about it.